PA007598.r2a:In Vivo Grade Recombinant Anti-human GM-CSF Monoclonal Antibody (Clone: BVD2-21C11.3), Rat IgG2a Kappa
Recombinant Rat IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: BVD2-21C11.3) specifically binds to human GM-CSF.
Applications:ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human GM-CSF protein.BP000176-CYT-221: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.1 ng/ml, corresponding to a Specific Activity of 11,100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000176-CYT-324: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, Pichia
Source:Pichia Pastoris-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.183 ng/ml, corresponding to a Specific Activity of 5.5 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000175-CYT-018: Recombinant Human Granulocyte colony-stimulating factor (G-CSF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependent proliferation of murine NFS-60 indicator cells is less than 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 95% by SEC-HPLC.BP000176-C003: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 107 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000175-CYT-476: Recombinant Human Granulocyte colony-stimulating factor (G-CSF) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000175-C002: Recombinant Human Granulocyte colony-stimulating factor (G-CSF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of murine NFS-60 indicator cells is less then 0.1 ng/ml, corresponding to a Specific Activity of 6.0x 107 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000176-CYT-089: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.4-2 ng/ml.
Purity: > 95% by SDS-PAGE.BP000175-C028: Recombinant Human Granulocyte colony-stimulating factor (G-CSF) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of murine NFS-60 indicator cells is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 107 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000176-CYT-416: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, Sf9
Source: Insect Cells-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE.